Case-Based Roundtables on TargetedOnc.com are collaborative, small-group discussions about case-based clinical profiles and engaging peer-dialogue led by an expert physician. These resources offer practicing oncologists and hematologists insight on relevant data, treatment strategies, and varying professional opinions.
LATEST LUNG CANCER CONTENT
ROS1+ NSCLC: Key Takeaways From Case-Based Roundtables With Dr Santos
The Gap Between What Oncologists Have Been Prescribing and What the ROS1 Data Now Supports
TMB, Tumor Burden, and Tailoring Immunotherapy in Lung Cancer
Checkpoint Inhibitors in Lung Cancer: When One Drug Isn't Enough
Taletrectinib and Brain Metastases in Non–Small Cell Lung Cancer
Clinical Utility of KEAP1 and STK11 in NSCLC
Precision or Urgency? Managing PD-L1 Testing in Metastatic NSCLC
Immunotherapy Choices and High Attrition Rates in SCLC
CASE-BASED ROUNDTABLES
Advertisement
Advertisement